RBR-3yg34rCompleted未知
Study of pharmacotherapeutic from the Clinical Protocol and Therapeutic Guidelines (PCDT / MS) of dyslipidemia applied to the Pharmaceutical Care Service of the 4th Regional of Irati-PR and evaluation of service satisfaction: A pharmacoepidemiological approach
niversidade Estadual de Maringá0 sitesStarted: June 27, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 18Y to 100Y (—)
Inclusion Criteria
- •Patients diagnosed with dyslipidemia; using drugs from the Specialized Component of Pharmacy Assistance for dyslipidemia; over 18 years old; polymedicated; with more than 3 comorbidities.
Exclusion Criteria
- •Pregnant women; under 18; alcoholics; psychiatric disorder.
Investigators
Similar Trials
Recruiting
Not Applicable
Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.Colorectal CancerJPRN-UMIN000013939Showa University School of Medicine100
Recruiting
Phase 2
To evaluate the Safety and efficacy of Unani formulations Zimad e Bars in Kalaf (Melasma)CTRI/2015/11/006385Central Council for Research in Unani Medicine300
Completed
Not Applicable
A study to evaluate the Pharmacokinetics and Pharmacodynamics of tolvaptan in congestive heart failure patients with renal impairmentCongestive heart failureJPRN-UMIN000006859St. Marianna University Hospital18
Active, not recruiting
Phase 1
A CLINICAL PHARMACOLOGY STUDY TO EVALUATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF NXT007 WITH A NEW PREPARATION METHOD IN HEALTHY JAPANESE MALE ADULTSHemophilia AJPRN-jRCT2031220050Takehiko Sambe30
Not yet recruiting
Phase 3
Comparative Clinical Study of Kariradi Vaginal Wash and Clotrimazole in ShwetapradarCTRI/2024/07/069717DrApurva Chandrakant Karande